Bank rescue: The EU Court of Justice says that the financial stability if EU financial markets prevails over the shareholders’ rights
The judgment handed down the Court of Justice of the
EU (CJEU) in Dowling and Others[1]
focuses on the interaction between reorganization measures adopted by a EU
Member States on the basis of EU Law and the protection of the rights of
shareholders and creditors enshrined by the Second Company Directive. In that
judgment, consistently with its past case law, the CJEU reached the conclusion that,
in some circumstances, the need to preserve the stability of financial markets
prevails should be preferred over the protection of shareholders’ rights.
Irish Life and Permanent (ILP), now Permanent TSB, was
a credit institution (the Bank) operating in Ireland, whose share capital of
ILP was wholly owned by Irish Life and Permanent Group holdings (ILPGH or the
Company), now Permanent Group Holdings. Sadly, the Bank was severely affected
by 2008 financial crisis. Under the 2010 Memorandum of Understanding signed by
Ireland with the European Commission and in accordance to the EU Decision
2011/77, Ireland committed to recapitalize the national banks on the basis of
the results of the Prudential Capital Assessment Review (PCAR) and a Prudential
Liquidity Assessment Review (PLAR) to be conducted by the Central Bank of
Ireland. Compliance with such commitments was a necessary condition for making
available to Ireland the financial assistance provided for by Regulation
407/2010 pursuant to the European financial stabilisation mechanism. The
deadline to recapitalize ailing banks was July 2011.
The results of the PCAR and PLAR were not positive for
ILP and accordingly the Central Bank of Ireland ordered the Bank to raise
additional capital of € 4 billion. Later in 2011 the MF made a proposal to the
ILPGH shareholders to raise the required additional capital. Interestingly, the
MP proposal did not consist in rising the capital of the Bank, but rather in
increasing the capital of the Company with a capital injection of € 2,7
billion. The extraordinary general meeting of ILPGH, however, rejected this
proposal, preferring alternative options. Pursuant to the Credit Institution
(Stabilisation) Act 2010 (the 2010 Act) the MF filed with the High Court an
application for a direction order that was adopted by the court. In practice,
by the direction order the High Court imposed on ILPGH to issue, in return for
the capital injection of € 2,7 billion, new shares in favour to the MF at the
prices determined by the latter and 10% lower than the quoted share price of 23
June 2011. The result of the direction order was that the MF owned 99,2% of the
share capital of the Company without the approval of the general meeting of
ILPGH. Accordingly, the shares of the Company were also delisted from the Irish
and London Stock Exchanges.
Mr. Dowling and other individual shareholder of the
Company appealed the direction order before the High Court, claiming that the
share capital increase was carried out in violation of Articles 8(1)[2],
25[3]
and 29[4]
of the Second Company Directive. The High Court stayed proceedings and referred
a preliminary question to the CJEU pursuant to Article 267 TFEU. What the High
Court asked was whether Articles 8, 25 and 29 of the Second Company Directive should
be interpreted as precluding a measure, such as the challenged direction order
adopted in presence of a serious disturbance of the economy and financial
system of a Member States threatening the EU financial stability, the effect of
which was: i) to increase the share capital of a public limited liability
company, without the approval of the general meeting of that company; ii) the
issue of shares at a price lower than their nominal value; iii) the refusal to
grant to the existing shareholders any right pre-emptive right to subscribe the
new rights issue.
The CJEU started by pointing out that the EU Decision
2011/77 imposed the obligation for the recapitalization of banks but it did not
specify in which way the ailing banks should be recapitalized. Accordingly, the
Irish authorities could fulfill this obligation also by increasing the share
capital of ILPGH. Moreover, the challenged direction order handed down by the
High Court was the only means of complying with the obligation within the
deadline.
That said, the CJEU went on by dealing with the
question whether the shareholders’ rights can be compressed to preserve the
financial stability of markets. In that regard, the CJEU considered that the
protection of shareholders and creditors enshrined in the Second Company
Directive does not apply to national measures, like the decision order. More
precisely, such measures are adopted in a scenario where there is a serious
disturbance of the economy and financial system of a Member States. These
measures are aimed to deal with the threats to the EU financial stability
coming from a capital shortfall in the company concerned. Consistently with its
previous judgment in Kotnick and Others[5],
the CJEU ruled that under the above circumstances is possible to adopt
exceptional measures affecting the share capital of a public limited liability
company, without the approval of the general meeting of that company thereby disregarding
the provisions in the Second Company Directive. Such measures, as stressed by
the CJEU, can be adopted where there is a serious disturbance of the economy
and financial system of a Member States with the objective of preventing a
systemic risk and ensuring the financial stability of the EU. Therefore, the
Second Company Directive cannot be invoked to prevent the adoption of a measure
like the decision order.
The CJEU also distinguished the facts of Dowling and Others from those of Pafitis and Others[6].
In that case, which was about the insolvency of a single bank, the CJEU ruled
that the Second Company Directive applied to ordinary reorganization measures,
whereas it did not adjudicate on extraordinary reorganization measures to be
adopted in case of danger for the EU
financial stability. The CJEU also made the point that its judgment in Pafitis and Others was released before
the start of the third stage of the implementation of the Economic and Monetary
Union with the related amendments to the EU Treaties. Crucially at this point,
the CJEU noted that, though that there is a clear public interest recognized
throughout the EU to a strong protection of the rights of shareholders and
creditors, such interest cannot always prevail over the public interest in
preserving the stability of financial systems resulting from the completion of the
Economic and Monetary Union. This ruling mirrored what the CJEU held before in Kotnick and Others.
Therefore, the CJEU replied to questions posed by the
referring court by ruling that: Article 8(1) and Articles 25 and 29 of the
Second Company Directive must be interpreted as not precluding a measure, such
as the Direction Order at issue in the main proceedings, adopted in a situation
where there is a serious disturbance of the economy and the financial system of
a Member State threatening the financial stability of the EU, the effect of
that measure being to increase the share capital of a public limited liability
company, without the agreement of the general meeting of that company, new
shares being issued at a price lower than their nominal value and the
existing shareholders being denied any pre-emptive subscription right.
In conclusion, in Dowling
and Others the CJEU weighted two conflicting interests: the interest in the
protection of the rights the Second Company Directive confers on shareholders
and creditors of a company; the interest to preserve the financial stability of
EU markets from systemic risks. The CJEU ruled that the preservation of
financial stability prevails over the protection of the rights of the
shareholders and creditors provided two conditions are met: i) the measure
restricting the rights of shareholders and creditors is adopted when a serious
disturbance of the economy and the financial system of a Member State exist
that threatens the EU financial stability; ii) the measure is designed to overcome
such systemic threat. Dowling and Others
strengthens the idea that Member States may adopt extraordinary reorganization
measures to recapitalize ailing banks to dela with systemic risk threatening the
stability of the EU financial markets. It is noteworthy that by the implementation
of the capital injection, the MF would substantially confiscate the previous
shareholders of the Company of all their shares in the equity capital of ILPGH.
In practice, the direction order amounted to a burden-sharing measure targeting
the shareholders of the Company. In that regard, Dowling and Others is consistent with the principles of
burden-sharing and bail-in that, in accordance with the Bank Recovery and
Resolution Directive (BRRD) apply to public intervention to rescue ailing
banks.
[1] Judgment of 8 November 2016, Case C-41/15, Dowling and Others v Minister for Finance, ECLI:EU:C:2016:836.
[2] Article 8 (1) lays down that: ‘Shares may not be issued at a price
lower than their nominal value, or, where there is no nominal value, their
accountable par’.
[3] Articles 25 rules that:
1.
Any increase in capital must be decided upon by the general meeting. Both this
decision and the increase in the subscribed capital shall be published in the
manner laid down by the laws of each Member State, in accordance with Article 3
of Directive 68/151/EEC.
2.
Nevertheless, the statutes or instrument of incorporation or the general
meeting, the decision of which must be published in accordance with the rules
referred to in paragraph 1, may authorize an increase in the subscribed capital
up to a maximum amount which they shall fix with due regard for any maximum
amount provided for by law. Where appropriate, the increase in the subscribed
capital shall be decided on within the limits of the amount fixed, by the
company body empowered to do so. The power of such body in this respect shall
be for a maximum period of five years and may be renewed one or more times by
the general meeting, each time for a period not exceeding five years.
3.
Where there are several classes of shares, the decision by the general meeting
concerning the increase in capital referred to in paragraph 1 or the
authorization to increase the capital referred to in paragraph 2, shall be
subject to a separate vote at least for each class of shareholder whose rights
are affected by the transaction.
4.
This Article shall apply to the issue of all securities which are convertible
into shares or which carry the right to subscribe for shares, but not to the
conversion of such securities, nor to the exercise of the right to subscribe.
[4] Articles 29 rules that:
1. Whenever the capital is increased by
consideration in cash, the shares must be offered on a pre-emptive basis to
shareholders in proportion to the capital represented by their shares.
2. The laws of a Member State: (a) need not
apply paragraph 1 above to shares which carry a limited right to participate in
distributions within the meaning of Article 15 and/or in the company's assets
in the event of liquidation ; or (b) may permit, where the subscribed capital
of a company having several classes of shares carrying different rights with
regard to voting, or participation in distributions within the meaning of
Article 15 or in assets in the event of liquidation, is increased by issuing
new shares in only one of these classes, the right of pre-emption of
shareholders of the other classes to be exercised only after the exercise of
this right by the shareholders of the class in which the new shares are being
issued.
3. Any offer of subscription on a pre-emptive
basis and the period within which this right must be exercised shall be
published in the national gazette appointed in accordance with Directive
68/151/EEC. However, the laws of a Member State need not provide for such
publication where all a company's shares are registered. In such case, all the
company's shareholders must be informed in writing. The right of pre-emption
must be exercised within a period which shall not be less than 14 days from the
date of publication of the offer or from the date of dispatch of the letters to
the shareholders.
4. The right of pre-emption may not be
restricted or withdrawn by the statutes or instrument of incorporation. This
may, however, be done by decision of the general meeting. The administrative or
management body shall be required to present to such a meeting a written report
indicating the reasons for restriction or withdrawal of the right of
pre-emption, and justifying the proposed issue price. The general meeting shall
act in accordance with the rules for a quorum and a majority laid down in
Article 40. Its decision shall be published in the manner laid down by the laws
of each Member State, in accordance with Article 3 of Directive 68/151/EEC.
5. The laws of a Member State may provide that
the statutes, the instrument of incorporation or the general meeting, acting in
accordance with the rules for a quorum, a majority and publication set out in
paragraph 4, may give the power to restrict or withdraw the right of
pre-emption to the company body which is empowered to decide on an increase in
subscribed capital within the limits of the authorized capital. This power may
not be granted for a longer period than the power for which provision is made
in Article 25 (2).
6. Paragraphs 1 to 5 shall apply to the issue of
all securities which are convertible into shares or which carry the right to
subscribe for shares, but not to the conversion of such securities, nor to the
exercice of the right to subscribe.
7. The right of pre-emption is not excluded for
the purposes of paragraphs 4 and 5 where, in accordance with the decision to
increase the subscribed capital, shares are issued to banks or other financial
institutions with a view to their being offered to shareholders of the company
in accordance with paragraphs 1 and 3.
[5] Judgment of 19 July 2016, Kotnik
and Others, C-526/14, EU:C:2016:570.
[6] Judgment of 12 March 1996, Pafitis
and Others, C-441/93, EU:C:1996:92.
Comments